No abstract available
MeSH terms
-
Angiotensin II*
-
Angiotensinogen / genetics
-
Animals
-
Animals, Genetically Modified
-
Aspirin / administration & dosage
-
Aspirin / pharmacology*
-
Aspirin / therapeutic use
-
CD4-Positive T-Lymphocytes / pathology
-
CD8-Positive T-Lymphocytes / pathology
-
Gene Expression
-
Heart Diseases / chemically induced
-
Heart Diseases / prevention & control*
-
Humans
-
I-kappa B Kinase
-
Kidney / blood supply
-
Kidney / chemistry
-
Kidney Diseases / chemically induced
-
Kidney Diseases / prevention & control*
-
Macrophages / pathology
-
Monocytes / pathology
-
Myocarditis / pathology
-
Myocarditis / prevention & control
-
Myocardium / chemistry
-
NF-kappa B / antagonists & inhibitors*
-
Nephritis / pathology
-
Nephritis / prevention & control
-
Protein Serine-Threonine Kinases / antagonists & inhibitors
-
Rats
-
Renin / genetics
-
Transcription Factor AP-1 / antagonists & inhibitors
-
Vascular Cell Adhesion Molecule-1 / analysis
Substances
-
NF-kappa B
-
Transcription Factor AP-1
-
Vascular Cell Adhesion Molecule-1
-
Angiotensinogen
-
Angiotensin II
-
Protein Serine-Threonine Kinases
-
CHUK protein, human
-
I-kappa B Kinase
-
IKBKB protein, human
-
IKBKE protein, human
-
Renin
-
Aspirin